// App-Quantinova.ai

2720 : Brief Chemoimmunotherapy Rituximab, Bendamustine, Mitoxantrone (R-BM) Followed by Rituximab Consolidation in Elderly Patients with Untreated Advanced Stage Follicular Lymphoma (FL): Preliminary Results of a Prospective Phase II Study by Fondazione Italiana Linfomi (FIL).

Researchers

Presenter

  • Marco Ladetto

Principal Investigators

  • Silvia Bolis

  • Silvia Franceschetti

  • Paola Riccomagno

  • Chiara Rusconi

  • Alfonso Zaccaria

  • Caterina Stelitano

  • Anna Marina Liberati

  • Chiara Ciochetto

  • Luca Baldini

  • Monica Balzarotti

  • Luca Arcaini

  • Alessandra Tucci

  • Umberto Vitolo

  • Manuela Ceccarelli

  • Chiara Lobetti-Bodoni

  • Stefano Volpetti

  • Lorella Orsucci

  • Annalisa Chiarenza

  • Roberto Freilone

  • Paolo Corradini

Medical Centers

  • Citta della Salute e della Scienza Hospital of Turin, Rheumatology Unit, Turin, Italy

  • Azienda Ospedaliera Citta della Salute e della Scienza di Torino, Hematology , Turin, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Follicular lymphoma

  • Neutropenia

  • Lymphomas

  • Solid malignancies

  • Ulcerative colitis

Biomarkers

  • B-cell lymphoma 2

  • Circulating tumor cells

Drug/Treatment

  • Bendamustine

  • Mitoxantrone

  • fludarabine tablet

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved